Showing 21-30 of 32 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| GNTI-122 for the treatment of recently diagnosed type 1 diabetes | GentiBio | Mark Bach | Cures | 01-December-2025 to 30-November-2027 | $4,000,000.00 |
| Subcutaneous In Vivo Engraftment and Vascularization of 3D Bioprinted Pancreatic-Like Tissue | FluidForm Bio | Adam Feinberg | Cures | 23-December-2025 to 12-June-2026 | $228,696.00 |
| ALIGN-T1D Start-Up Secretariat | Clinton Health Access Initiative (CHAI) | Colin Brown | Mission | 01-October-2025 to 31-March-2027 | $822,000.00 |
| Closing the T1D diagnosis gap in Ethiopia, Ghana and Nigeria | Clinton Health Access Initiative (CHAI) | Margaret Prust | Mission | 01-September-2023 to 31-August-2026 | $1,702,076.57 |
| Harnessing Neonatal Regulatory T Cells for Precision Immunotherapy in Type 1 Diabetes | Boston Children’s Hospital | Ayano Kohlgruber | Cures | 01-March-2026 to 28-February-2031 | $998,713.47 |
| Engineering fully vascularized SC-islets through endothelial integration and endocrine-vascular crosstalk | Boston Children’s Hospital | Juan Melero-Martin | Cures | 01-November-2025 to 31-October-2027 | $599,994.46 |
| Engineered Nanobodies to Visualize and Direct Antigen-Specific Tolerance in T1D | Boston Children’s Hospital | Novalia Pishesha | Cures | 01-March-2025 to 28-February-2030 | $999,999.00 |
| A wireless oxygen generating immune protection device to support long term cell transplantation for the treatment of Type I Diabetes | Boston Children’s Hospital | Robert Langer | Cures | 01-August-2025 to 31-July-2028 | $2,481,286.98 |
| Reducing Health Disparities and Improving Outcomes in Type 1 Diabetes Through a Novel Community-Focused Digital Care Model | Blue Circle Health | Leonard D’Avolio | Mission | 01-January-2026 to 31-December-2028 | $1,500,000.00 |
| New lipid biomarker to predict early risk for Type 1 diabetes | Beth Israel Deaconess Medical Center Inc | Barbara Kahn | Cures | 01-September-2024 to 31-August-2027 | $899,997.53 |